DILLARDS INC-CL A (DDS)
US2540671011 - Common Stock
Taking everything into account, DDS scores 6 out of 10 in our fundamental rating. DDS was compared to 34 industry peers in the Broadline Retail industry. DDS gets an excellent profitability rating and is at the same time showing great financial health properties. DDS has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DDS had positive earnings in the past year.
In the past year DDS had a positive cash flow from operations.
DDS had positive earnings in 4 of the past 5 years.
In the past 5 years DDS always reported a positive cash flow from operatings.
1.2 Ratios
DDS has a Return On Assets of 21.42%. This is amongst the best in the industry. DDS outperforms 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 43.54%, DDS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
DDS's Return On Invested Capital of 27.82% is amongst the best of the industry. DDS outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DDS is significantly above the industry average of 11.22%.
The last Return On Invested Capital (27.82%) for DDS is well below the 3 year average (34.48%), which needs to be investigated, but indicates that DDS had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 21.42% | ||
| ROE | 43.54% | ||
| ROIC | 27.82% |
ROA(3y)24.93%
ROA(5y)15.14%
ROE(3y)52.91%
ROE(5y)32.12%
ROIC(3y)34.48%
ROIC(5y)N/A
1.3 Margins
DDS has a better Profit Margin (10.75%) than 84.85% of its industry peers.
In the last couple of years the Profit Margin of DDS has grown nicely.
DDS has a Operating Margin of 13.18%. This is amongst the best in the industry. DDS outperforms 87.88% of its industry peers.
In the last couple of years the Operating Margin of DDS has grown nicely.
DDS's Gross Margin of 41.36% is fine compared to the rest of the industry. DDS outperforms 60.61% of its industry peers.
DDS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.18% | ||
| PM (TTM) | 10.75% | ||
| GM | 41.36% |
OM growth 3YN/A
OM growth 5Y26.89%
PM growth 3YN/A
PM growth 5Y32.63%
GM growth 3Y10.36%
GM growth 5Y3.99%
2. Health
2.1 Basic Checks
DDS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, DDS has less shares outstanding
The number of shares outstanding for DDS has been reduced compared to 5 years ago.
Compared to 1 year ago, DDS has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of DDS is 0.69, which is an excellent value as it means it would take DDS, only 0.69 years of fcf income to pay off all of its debts.
DDS has a Debt to FCF ratio of 0.69. This is amongst the best in the industry. DDS outperforms 81.82% of its industry peers.
DDS has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
DDS has a Debt to Equity ratio of 0.31. This is comparable to the rest of the industry: DDS outperforms 51.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.69 | ||
| Altman-Z | N/A |
ROIC/WACC2.81
WACC9.89%
2.3 Liquidity
A Current Ratio of 2.67 indicates that DDS has no problem at all paying its short term obligations.
The Current ratio of DDS (2.67) is better than 93.94% of its industry peers.
A Quick Ratio of 1.35 indicates that DDS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.35, DDS is in the better half of the industry, outperforming 60.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.67 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
The earnings per share for DDS have decreased strongly by -12.04% in the last year.
Measured over the past years, DDS shows a very strong growth in Earnings Per Share. The EPS has been growing by 48.60% on average per year.
Looking at the last year, DDS shows a decrease in Revenue. The Revenue has decreased by -1.74% in the last year.
Measured over the past years, DDS shows a small growth in Revenue. The Revenue has been growing by 1.12% on average per year.
EPS 1Y (TTM)-12.04%
EPS 3YN/A
EPS 5Y48.6%
EPS growth Q2Q-8.58%
Revenue 1Y (TTM)-1.74%
Revenue growth 3Y15.75%
Revenue growth 5Y1.12%
Revenue growth Q2Q-0.17%
3.2 Future
Based on estimates for the next years, DDS will show a very negative growth in Earnings Per Share. The EPS will decrease by -27.24% on average per year.
Based on estimates for the next years, DDS will show a decrease in Revenue. The Revenue will decrease by -3.75% on average per year.
EPS Next Y-31.51%
EPS Next 2Y-16.26%
EPS Next 3Y-27.24%
EPS Next 5YN/A
Revenue Next Year-2.43%
Revenue Next 2Y-0.94%
Revenue Next 3Y-3.75%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.05 indicates a reasonable valuation of DDS.
DDS's Price/Earnings ratio is a bit cheaper when compared to the industry. DDS is cheaper than 78.79% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.25. DDS is valued rather cheaply when compared to this.
DDS is valuated correctly with a Price/Forward Earnings ratio of 14.67.
66.67% of the companies in the same industry are more expensive than DDS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.67. DDS is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.05 | ||
| Fwd PE | 14.67 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DDS is valued cheaper than 84.85% of the companies in the same industry.
84.85% of the companies in the same industry are more expensive than DDS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.71 | ||
| EV/EBITDA | 6.09 |
4.3 Compensation for Growth
The excellent profitability rating of DDS may justify a higher PE ratio.
DDS's earnings are expected to decrease with -27.24% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2Y-16.26%
EPS Next 3Y-27.24%
5. Dividend
5.1 Amount
With a yearly dividend of 0.25%, DDS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.41, DDS pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.25, DDS pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
5.2 History
On average, the dividend of DDS grows each year by 118.48%, which is quite nice.
DDS has paid a dividend for at least 10 years, which is a reliable track record.
DDS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)118.48%
Div Incr Years10
Div Non Decr Years10
5.3 Sustainability
DDS pays out 45.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP45.83%
EPS Next 2Y-16.26%
EPS Next 3Y-27.24%
DILLARDS INC-CL A
NYSE:DDS (4/24/2024, 7:04:00 PM)
After market: 449.27 0 (0%)449.27
+5.17 (+1.16%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.29B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.05 | ||
| Fwd PE | 14.67 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 21.42% | ||
| ROE | 43.54% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 13.18% | ||
| PM (TTM) | 10.75% | ||
| GM | 41.36% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.67 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-12.04%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-31.51%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.74%
Revenue growth 3Y15.75%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y